French Angiogenesis Society partners with Targeted Oncology Fabrice Soncin Editorial 25 March 2010 Pages: 1 - 1
The search for optimal response prediction in cancer leads to a personalized approach Eric Van CutsemFortunato Ciardiello Editorial 28 March 2010 Pages: 3 - 4
Impact of biomarkers on non-small cell lung cancer treatment Luca ToschiFederico Cappuzzo Review 05 May 2010 Pages: 5 - 17
Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer Andrea Sartore-BianchiKatia BencardinoSalvatore Siena Review 11 April 2010 Pages: 19 - 28
Molecular response prediction in gastrointestinal stromal tumors Philippe A. CassierJean-Yves Blay Review 02 April 2010 Pages: 29 - 37
Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy Anwar R. PadhaniAftab Alam Khan Review 11 April 2010 Pages: 39 - 52
Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment Nathalie LassauMohamed ChebilAlain Roche Review 09 April 2010 Pages: 53 - 58
Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report Sean Xiang WangAbigail ByrnesOlivier Rixe Day-to-Day Practice 23 March 2010 Pages: 59 - 63
Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents Christophe Le TourneauVéronique DiérasXavier Paoletti Perspectives 02 April 2010 Pages: 65 - 72